Brief: Iteos Provides Business Updates And Clinical Development Plans For 2023

iTeos Therapeutics

09/01/2023 13:09

Jan 9 (Reuters) - Iteos Therapeutics Inc  ITOS.O :
    * ITEOS PROVIDES BUSINESS UPDATES AND CLINICAL DEVELOPMENT
PLANS
FOR 2023
    * ITEOS THERAPEUTICS INC - EOS-984, PROGRAM TARGETING
MECHANISM OF
ACTION IN ADENOSINE PATHWAY, EXPECTED TO ENTER CLINICAL STUDIES
MID-2023
    * ITEOS THERAPEUTICS-CASH BALANCE OF $752MM AS OF SEPT 30,
2022,
EXPECTED TO PROVIDE RUNWAY INTO 2026 THROUGH MULTIPLE INFLECTION
POINTS ACROSS PORTFOLIO
    * ITEOS THERAPEUTICS INC - ELEVEN CLINICAL TRIALS PLANNED OR
ONGOING AGAINST MULTIPLE TUMOR TYPES, ACROSS THREE PIPELINE
PROGRAMS

Source text for Eikon:  ID:nGNXchhf97 
Further company coverage:  ITOS.O 
 ((Reuters.Briefs@thomsonreuters.com;))